With increasing rates of depression worldwide, clinicians are rethinking traditional treatment frameworks by integrating major depressive disorder and treatment innovations into routine psychiatric care. New approaches such as esketamine nasal spray, deep brain stimulation, and digital therapeutics are reshaping how depression is addressed, particularly in treatment-resistant populations. Psychotherapies like cognitive control training and acceptance-based strategies are also showing promising results. Combining neurobiological insights with technology, clinicians can now predict treatment response with greater accuracy, minimizing trial-and-error prescribing. This precision model supports faster recovery and fewer relapses. Emphasizing patient-centered care, new innovations allow for better symptom tracking, greater adherence, and reduced long-term impact on daily functioning.
Title : The Storm Within: Neuropsychological Insights into Dysregulation and Substance Use in the Adolescent Brain.
Ann Marie Leonard Zabel, Curry College, United States
Title : Sexualizing anxiety and anxiolytic sex: Misattribution of arousal
Sam Vaknin, CIAPS, Cambridge, United Kingdom
Title : Workplace and occupational mental health: Supporting well-being at work
Sindu Padmanabhan, Bharathiar University, India
Title : Resilience in counseling: Processing grief for the addictions counselor
Kayla Albers, Hazelden Betty Ford Graduate School, United States
Title : Resilience in counseling: Processing grief for the addictions counselor
Jorja Jamison, Hazelden Betty Ford Graduate School, United States
Title : Identity restoration as a missing variable in relapse prevention
Andrew Drasen, A Vision of Hope Media, United States